ATE239498T1 - Entzündungshemmende zusammensetzung - Google Patents

Entzündungshemmende zusammensetzung

Info

Publication number: ATE239498T1
Authority: AT; Austria
Prior art keywords: composition; alpha; inflammatory composition; treatment; msh
Prior art date: 1998-07-15

Application number

AT99401720T

Other languages

English (en)

Inventor

Yann Mahe

Nelly Billoni

Lionel Breton

Lien Bui-Bertrand

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-15

Filing date

1999-07-08

Publication date

2003-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9528645&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE239498(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-07-08 Application filed by Oreal filed Critical Oreal

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE239498T1 publication Critical patent/ATE239498T1/de

Links

230000003110 anti-inflammatory effect Effects 0.000 title 1
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 abstract 2
241000195493 Cryptophyta Species 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000004400 mucous membrane Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Birds (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Botany (AREA)
Microbiology (AREA)
Mycology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99401720T 1998-07-15 1999-07-08 Entzündungshemmende zusammensetzung ATE239498T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9809055A FR2781157B1 (fr)	1998-07-15	1998-07-15	Composition anti-inflammatoire

Publications (1)

Publication Number	Publication Date
ATE239498T1 true ATE239498T1 (de)	2003-05-15

Family

ID=9528645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99401720T ATE239498T1 (de)	1998-07-15	1999-07-08	Entzündungshemmende zusammensetzung

Country Status (7)

Country	Link
US (1)	US6337315B1 (de)
EP (1)	EP0972522B2 (de)
JP (1)	JP3746169B2 (de)
AT (1)	ATE239498T1 (de)
DE (1)	DE69907577T3 (de)
ES (1)	ES2199534T5 (de)
FR (1)	FR2781157B1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6803044B1 (en)	1999-03-24	2004-10-12	Zengen, Inc.	Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6887846B2 (en)	1999-03-24	2005-05-03	Zengen, Inc.	Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
US6800291B1 (en)	1999-03-24	2004-10-05	Zengen, Inc.	Uro-genital condition treatment system
US7402559B2 (en)	1999-03-24	2008-07-22	Msh Pharma, Incorporated	Composition and method of treatment for urogenital conditions
FR2806906A1 (fr) *	2000-04-04	2001-10-05	C F E B Sisley	Composition cosmetique comprenant un extrait d'algue brune agissant sur la quantite de gag
WO2002006316A2 (en) *	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
US6780838B2 (en)	2001-01-29	2004-08-24	Zengen, Inc.	Compounds for treating fungal pathologies of the oral cavity
ATE446949T1 (de) *	2001-03-19	2009-11-15	Senju Pharma Co	Neues a-liponsäurederivat und dessen verwendung
US6894028B2 (en) *	2001-04-06	2005-05-17	Zengen, Inc.	Use of KPV tripeptide for dermatological disorders
FR2826577B1 (fr) *	2001-06-29	2003-10-03	Oreal	Utilisation du tripeptide lys-pro-val (kpv) pour ameliorer la fonction barriere de la peau
US7115574B2 (en)	2001-12-10	2006-10-03	Zengen, Inc.	System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en)	2001-12-17	2005-09-06	Zengen, Inc.	Use of a polypeptide for treatment of pruritis in animals
FR2835528B1 (fr) *	2002-02-01	2004-03-12	Inst Europ Biolog Cellulaire	Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
FR2857581B1 (fr) *	2003-07-18	2007-11-30	Inst Europ Biolog Cellulaire	Association utile dans le traitement preventif et curatif de l'alopecie d'un agent anti-inflammatoire et d'un filtre uvb
FR2870242B1 (fr)	2004-05-11	2010-08-20	Inst Europeen Biologie Cellulaire	Peptides ou conjugues peptidiques derives de la msh et leur utilisation dans le traitement cosmetique de la canitie.
FR2870244B1 (fr)	2004-05-11	2011-01-07	Centre Nat Rech Scient	Conjugues dipeptidiques antagonistes de l'alpha-msh
FR2870243B1 (fr)	2004-05-11	2010-11-19	Centre Nat Rech Scient	Conjugues tripeptidiques agonistes de la msh
JP5324781B2 (ja) *	2004-06-14	2013-10-23	ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス	Ｐｔｈ断片含有化粧品
EP1998791A4 (de) *	2006-03-30	2009-11-04	Salpep Biotechnology Inc	Unterdrückung und behandlung von neuropathischen schmerzen
FR2900573B1 (fr)	2006-05-05	2014-05-16	Sederma Sa	Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
US20070292535A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating osteoporotic conditions
DE102009055970B4 (de) *	2009-11-27	2014-04-17	Marcus Asam	Kosmetische Wirkstoffzubereitung
US9200236B2 (en)	2011-11-17	2015-12-01	Heliae Development, Llc	Omega 7 rich compositions and methods of isolating omega 7 fatty acids
KR20170134653A (ko) *	2015-04-08	2017-12-06	디에스엠 아이피 어셋츠 비.브이.	배합물
US10149811B2 (en) *	2016-02-11	2018-12-11	Elc Management Llc	Methods and compositions for stimulating collagen synthesis in skin cells
CN109844128A (zh) *	2016-10-21	2019-06-04	株式会社资生堂	层粘连蛋白511产生促进剂、表皮基底膜稳定剂和/或表皮干细胞减少抑制或增加促进剂的筛选方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5028592A (en) *	1986-08-08	1991-07-02	Lipton James M	Antipyretic and anti-inflammatory peptides
US5157023A (en) *	1984-08-21	1992-10-20	Lipton James M	Antipyretic and anti-inflammatory lys pro val compositions and method of use
WO1994013624A1 (fr) *	1992-12-09	1994-06-23	Kyowa Hakko Kogyo Co., Ltd.	Derive de n-acylglutamine
WO1994024984A2 (en) *	1993-04-30	1994-11-10	Winget Rodner R	Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
FR2710340B1 (fr) *	1993-09-22	1995-12-15	D Hinterland Lucien Dussourd	Dérivés peptidiques de l'alpha-MSH et leur application .
US5618850A (en) *	1995-03-09	1997-04-08	Focal, Inc.	Hydroxy-acid cosmetics
FR2733421B1 (fr) *	1995-04-28	1997-06-06	Oreal	Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2753628B1 (fr) *	1996-09-26	1998-11-20		Produit destine a prevenir et a soigner les maladies de la peau, procede d'elaboration et utilisation dudit produit
DE19653736C2 (de) †	1996-12-12	2002-11-21	Lancaster Group Gmbh	Kosmetisches Präparat mit Peptidzusatz

1998
- 1998-07-15 FR FR9809055A patent/FR2781157B1/fr not_active Expired - Fee Related
1999
- 1999-07-08 AT AT99401720T patent/ATE239498T1/de not_active IP Right Cessation
- 1999-07-08 ES ES99401720T patent/ES2199534T5/es not_active Expired - Lifetime
- 1999-07-08 EP EP99401720A patent/EP0972522B2/de not_active Expired - Lifetime
- 1999-07-08 DE DE69907577T patent/DE69907577T3/de not_active Expired - Lifetime
- 1999-07-14 JP JP20104299A patent/JP3746169B2/ja not_active Expired - Lifetime
- 1999-07-15 US US09/353,650 patent/US6337315B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69907577T2 (de)	2004-04-08
FR2781157A1 (fr)	2000-01-21
US6337315B1 (en)	2002-01-08
EP0972522B2 (de)	2007-10-31
EP0972522B1 (de)	2003-05-07
DE69907577T3 (de)	2008-03-06
ES2199534T5 (es)	2008-04-16
JP2000080024A (ja)	2000-03-21
FR2781157B1 (fr)	2000-08-25
EP0972522A1 (de)	2000-01-19
JP3746169B2 (ja)	2006-02-15
DE69907577D1 (de)	2003-06-12
ES2199534T3 (es)	2004-02-16

Publication	Publication Date	Title
DE69907577D1 (de)	2003-06-12	Entzündungshemmende Zusammensetzung
CA2279967A1 (en)	1998-08-06	Method of enhancing hair growth
AU5857498A (en)	1998-07-31	Cosmetic preparations containing extracts from phyllantus emblica and centella asiatica and/or bacopa monnieri
ES2102921T3 (es)	1997-08-01	Utilizacion de derivados de la hormona estimuladora de los melanocitos de tipo alfa para estimular el crecimiento de los cabellos.
BR9704843B1 (pt)	2009-01-13	hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
FI973468L (fi)	1997-08-22	Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
MX9801596A (es)	1998-08-30	Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
MXPA02012075A (es)	2004-08-19	Composicion para mediar el dolor y aparato y metodo para utilizarla.
BR0115990A (pt)	2004-01-06	Preparações cosméticas e/ou dermofarmacêutica contendo proteìnas nativas da planta argania spinosa
BR9811755A (pt)	2000-08-29	Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
EP0214254A1 (de)	1987-03-18	Melatoninhaltige mittel sowie deren verwendungen.
EA200501069A1 (ru)	2006-08-25	Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи
DK0700897T3 (da)	1999-02-01	L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
EP0821969A3 (de)	2000-12-13	Arzneimittelzusammensetzung enthaltend TCF-II
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69900774D1 (de)	2002-02-28	Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
EP1020192A3 (de)	2000-10-04	Anticellulitiszusammensetzung und ihre Verwendung
IT1251497B (it)	1995-05-15	Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
MXPA01006011A (es)	2004-04-05	Composicion para tratamiento de quemaduras.
ES2088682T3 (es)	1996-08-16	Agente bronceador de la piel.
MX9307320A (es)	1994-06-30	Proteina substancialmente pura para la inhibicion de la melanogenesis en celulas pigmentarias, metodo para su produccion y metodo para el control de la melanogenesis en celulas pigmentarias.
DE69825322D1 (de)	2004-09-02	Topische carbamazepin-formulierungen und deren verwendung
RU96109746A (ru)	1998-08-10	Способ введения настоя цветков календулы лекарственной
RU96100994A (ru)	1998-03-27	Лечебно-косметическое средство
ZA979135B (en)	1998-06-24	New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.

Legal Events

Date	Code	Title	Description
2003-08-15	UEP	Publication of translation of european patent specification	Ref document number: 0972522 Country of ref document: EP
2008-01-15	UEP	Publication of translation of european patent specification	Ref document number: 0972522 Country of ref document: EP
2009-04-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2003-08-15

UEP

Publication of translation of european patent specification

Ref document number: 0972522

Country of ref document: EP

2008-01-15

UEP